Clinical Trials Directory

Trials / Completed

CompletedNCT00226564

Genetic Determinants of Opioids Analgesia

The Effect of mu Opioid Receptor Polymorphism on the Response to Alfentanil During Lithotripsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (planned)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The response to opioids varies greatly among individuals. Some of these variability is accounted for by genetic factors. The present study was designed to evaluate the possibility that genetic polymorphism in the gene encoding for mu opioid receptor may explain variability in the response to alfentanil during lithotripsy.

Conditions

Interventions

TypeNameDescription
DRUGAlfentanil

Timeline

Start date
1997-08-01
First posted
2005-09-27
Last updated
2008-10-29

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00226564. Inclusion in this directory is not an endorsement.